1. Home
  2. PACK vs MRVI Comparison

PACK vs MRVI Comparison

Compare PACK & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACK
  • MRVI
  • Stock Information
  • Founded
  • PACK 1972
  • MRVI 2014
  • Country
  • PACK United States
  • MRVI United States
  • Employees
  • PACK N/A
  • MRVI 560
  • Industry
  • PACK Containers/Packaging
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • PACK Consumer Discretionary
  • MRVI Health Care
  • Exchange
  • PACK Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • PACK 313.3M
  • MRVI 350.1M
  • IPO Year
  • PACK N/A
  • MRVI 2020
  • Fundamental
  • Price
  • PACK $5.29
  • MRVI $2.42
  • Analyst Decision
  • PACK Buy
  • MRVI Hold
  • Analyst Count
  • PACK 3
  • MRVI 10
  • Target Price
  • PACK $7.17
  • MRVI $5.84
  • AVG Volume (30 Days)
  • PACK 1.3M
  • MRVI 1.5M
  • Earning Date
  • PACK 08-05-2025
  • MRVI 08-11-2025
  • Dividend Yield
  • PACK N/A
  • MRVI N/A
  • EPS Growth
  • PACK N/A
  • MRVI N/A
  • EPS
  • PACK N/A
  • MRVI N/A
  • Revenue
  • PACK $380,700,000.00
  • MRVI $219,830,000.00
  • Revenue This Year
  • PACK $10.14
  • MRVI N/A
  • Revenue Next Year
  • PACK $7.92
  • MRVI $7.23
  • P/E Ratio
  • PACK N/A
  • MRVI N/A
  • Revenue Growth
  • PACK 10.38
  • MRVI N/A
  • 52 Week Low
  • PACK $2.91
  • MRVI $1.67
  • 52 Week High
  • PACK $8.70
  • MRVI $9.60
  • Technical
  • Relative Strength Index (RSI)
  • PACK 67.12
  • MRVI 49.60
  • Support Level
  • PACK $5.02
  • MRVI $2.28
  • Resistance Level
  • PACK $6.31
  • MRVI $2.47
  • Average True Range (ATR)
  • PACK 0.33
  • MRVI 0.14
  • MACD
  • PACK 0.10
  • MRVI -0.01
  • Stochastic Oscillator
  • PACK 55.24
  • MRVI 27.45

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: